MEI Pharma, Inc. (MEIP)

[joseph53]

CNA Finance 7 December

What We Can Expect To See From MEIP Moving Forward

Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from MEIP moving forward. This opinion is heavily based on the data that was just released.The bottom line here is that MEIP is getting closer and closer to proving that Pracinostat is an effective treatment for elderly patients that are suffering from AML. With a 100% survival rate among those that achieved a complete response, it's clear that the data released today warrants further development of the treatment. With that said, I'm expecting to see news that the company is entering into the Phase III study relatively soon. Based on what we saw in both Phase I and Phase II, I'm expecting that the Phase III study will yield overwhelmingly positive results, ultimately pushing the treatment forward to a New Drug Application. Therefore, I'm expecting several positive catalysts to come for the stock. In each step on the way to FDA approval, we can expect to see an incredibly positive response in the market, driving MEIP higher and higher upward. So, if you're thinking about getting in on the gains, you're likely thinking about making the right decision here.